Naotaka Sunada

Moriguchi, 5708506, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials.

Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials.

Journal: Journal of psychiatric research
Published: February 16, 2021

Divergence of dose-response with asenapine: a cluster analysis of randomized, double-blind, and placebo control study.

Divergence of dose-response with asenapine: a cluster analysis of randomized, double-blind, and placebo control study.

Journal: CNS spectrums
Published: January 19, 2021

Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.

Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.

Journal: Neuropsychobiology
Published: January 19, 2019

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Journal: Journal of psychiatric research
Published: December 21, 2016

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials.

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials.

Journal: European archives of psychiatry and clinical neuroscience
Published: September 08, 2015

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

Journal: Neuropsychobiology
Published: August 05, 2015

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

Journal: BMC psychiatry
Published: April 17, 2015

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

Journal: Journal of clinical psychopharmacology
Published: March 31, 2015

Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients.

Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients.

Journal: Neuropsychobiology
Published: February 12, 2015

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Journal: European archives of psychiatry and clinical neuroscience
Published: December 26, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026